On July 31, 2026, the Health Resources and Services Administration (“HRSA”) announced a revised 340B Rebate Model Pilot Program (“2026 Pilot”) ...
The Trump administration advances a claims-based rebate model for select 340B drugs as a new bipartisan Senate bill would block it, forcing ...
Hospitals push CMS ditch 340B rebate model to require upfront Medicare drug prices, easing administrative burdens on rural and safety-net facilities.
Providers are urging the government to abandon any plans to implement after-the-fact rebates in the 340B drug discount program, arguing it would impose undue costs on hospitals and clinics and ...
The Health Resources and Services Administration’s (HRSA) announcement of the revised 340B Rebate Model Pilot Program is an ...
While a federal judge squashed earlier plans for a 340B rebate pilot program, HHS appears poised to relaunch its attempts to transform the drug pricing program. Less than two weeks after the federal ...
The HHS is scrapping a rebate pilot in the 340B drug discount program, ending the controversial trial before it got off the ground. The pilot would have allowed pharmaceutical manufacturers to give ...
HHS in a court filing on Thursday said it would scrap its current 340B Rebate Model Pilot Program and potentially restart the administrative process for such a program. These moves come after the 1st ...
HHS is weighing whether to redesign its 340B rebate model pilot program after two federal court rulings blocked its implementation and the agency formally agreed to abandon the initiative. On Feb. 13, ...
A new survey released this week is seeking to clarify much about the controversial 340B outpatient drug discount program, which has the industry split over its potential for abuse by hospitals. The ...
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) ...
Some New Mexico hospitals and clinics may soon have a bitter pill to swallow as federal officials consider major changes to a widely used drug discount program. At the behest of pharmaceutical ...